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The structural characterization f a new oligosaccharide antibiotic, Everninomicin-6 (EV-6), is 
described. Detailed fast-atom bombardment mass spectrometry (FAB-MS) studies along with 
NMR and chemical degradation methods were conducted to elucidate the structure of EV-6. 
The effects of the use of various matrices, including salt addition, on the quality of the FAB-MS 
were explored. The use of 3-nitro benzyl alcohol, dimethyl sulfoxide (DMSO), and NaC1 
produced the best results: an intense sodiated molecular ion plus structurely informative 
fragmentation. FAB-MS yields information providing the complete sugar sequence informa- 
tion for everninomicins, which is quite valuable to the elucidation of the structure of this 
complex oligosaccharide antibiotic. In addition, the results of accurate mass work with the 
molecular ion are consistent with the assigned structure. The use of electrospray ionization 
mass spectrometry (ESI-MS) and ESI-MS/MS for the study of EV-6 was investigated and was 
found to produce an abundant molecular ion with limited structural information. These results 
revealed that EV-6 resembled EV-D quite closely except for the absence of the nitrosugar and 
the replacement on ring g of the -CH2OCH 3 group with a -CH2OH group. (J Am Soc Mass 
Spectrom 1997, 8, 1134-1140) © 1997 American Society for Mass Spectrometry 
E verninomicins constitute an important group of 
oligosaccharide antibiotics, isolated from the fer- 
mentation broth for Micromonospora c rbonaceae 
[1], that are highly active against gram-positive bacteria 
including methicillin resistant staphylococci and vanco- 
mycin resistant enterococci. Everninomicin-D (EV-D) is 
the main component of the above fermentation broth 
and was the first member of this family of complex 
oligosaccharide antibiotics to be extensively studied 
and have its structure lucidated. EV-D has since been 
used as a template for the characterization of other 
everninomicin components as well as other oligosac- 
charides such as flambamycin, curamycin, and avila- 
mycin [2]. The structures of everninomicin B, C, D, 
everninomicin-2, and 13-384 components 1 and 5 were 
reported earlier [2-6]. 
With the increasing rowth of drug resistant strains 
of bacteria, a major effort is being directed towards the 
reevaluation of the efficacy of existing oligosaccharides 
and to the identification of new potential oligosaccha- 
ride antibiotics. It is, therefore, important o character- 
ize quickly all EV components isolated from the fer- 
mentation broth as part of any ongoing process to 
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identify potential antibiotic pharmaceuticals. Compo- 
nent 13-384-1 (Ziracin, Schering-Plough, Kenilworth, 
NJ) is the most promising drug candidate and is under- 
going extensive clinical trials to determine its activity 
against both sensitive and resistant strains. A minor 
antibiotic component, isolated from the fermentation 
producing everninomicin-B, was designated everni- 
nomicin-6 (EV-6). We now describe the structural de- 
termination of this novel component by chemical deg- 
radation methods, NMR methods, and fast-atom 
bombardment (FAB)-mass spectrometry [7]. 
Experimental 
Short column chromatography [8] of the crude antibi- 
otic complex gave in some fractions (50% acetone/ 
benzene) pure EV-6 1 as a crystalline solid (acetone/n- 
hexane), C57H84031C12 melting point (m.p.) 233-35 °C, 
"Ymax 1730 cm -1 (ester), FAB-MS m/z 1357 [M + Na] ÷. 
Methylation of EV-6 with diazomethane gave a mono- 
methyl ether 2, m.p. 247-50 °C (acetone/n-hexane), 
C58H86031C12, [o¢]~ + 4.3 ° (CHCI3), FAB-MS m/z 1371 
[M + Na] ÷. 13C NMR spectrum of 2 showed signals at 
120.4 and 119.7 ppm attributable to the orthoester 
carbon atoms [5]. 
Mild acid hydrolysis of 2 in a two-phase system [4] 
provided methyl-everninomicin-61 4 asa major product 
and methyl-everninomicin-60 6 as a minor product. 
Both 4 and 6 on treatment with methanolic diazometh- 
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ane underwent ready cleavage [4] to provide 8 as a 
common product, olgose-6 10 and evertetrose-6 13, 
respectively. The lactone 8, m.p. 200 °C, C22H28C12Olo 
was found to be identical by NMR, mass spectrometry, 
and thin-layer chromatography (TLC) to a degradation 
product of everninomicin-2 [5, 9, 10]. This indicated that 
the structural variation in EV-6 existed in the olgose-6 
10 portion of the molecule. 
Olgose-6 10 is a crystalline compound, m.p. 200- 
202 °C, C34H56021 [o(]~, -13.3 ° (CHC13). The proton 
magnetic resonance (PMR) spectrum of olgose-6 closely 
resembled that of olgose-D except the lack of one 
O-methyl group in the former. Treatment of olgose-6 10 
with methanolic p-toluene sulfonic acid [4] gave ever- 
tetrose-6 13 and an ester 15. The ester 15 was found 
identical (NMR, mass spectrometry, TLC) to the same 
degradation product isolated from everninomicins B 
[2], D [4], and 2 [5]. Permethylation of olgose-6 gave a 
compound 11 m.p. 192-194 °C, [c~]~ -13.3 ° (CHC13), 
identical (NMR, mass spectrometry, TLC) to permethy- 
lated olgose-D [4]. It now remained to show the posi- 
tion of the four O-methyl groups in olgose-6 by isola- 
tion of the individual sugars. 
Evertetrose-6 13, m.p. 174-176 °C, C27H,18017 , [ot]~ 
-23 ° (CHC13), showed in the PMR spectrum (pyridine) 
two secondary methyls, one tertiary methyl, three O- 
methyl groups, and four anomeric protons at 64.85 
(d,Jaa 7 Hz), 85.25 (s, w/2 J 2.5), 35.3 (dd, lae 2 Hz, laa 
8 Hz) and 85.67 (d, J 2 Hz). Prolonged aqueous hydro- 
lysis of evertetrose-6 13 gave D-curacose, evermicose, 
2-O-methyl-D-xylose [11], and 2-O-methyl-D-mannose 
16 [12], a sugar previously not isolated from everni- 
nomicins. Acetylation of 16 with pyridine-acetic anhy- 
dride yielded 1,3,4,6-tetra-O-acetyl-2-0-methyl-~-D- 
mannopyranose 17, m.p. 135-6 °C (acetone/n-hexane), 
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C15H22010, [a]~ +51.4 ° (CHC13). The PMR spectrum 
(CDC13) of 17 had expected signals at 86.2.2 (d, J 2.2 Hz, 
H1) , 3.65 (dd, J 2.2 and 3.0 Hz, H2) , 5.23 (J3,4 9 Hz, J3,2 3.0 
HZ, H3) , 5.40 (J3,4 J4.5 9.0 Hz,  H4) , 4.04 (m, Hs), 4.29 (J 12 
and 4.5 Hz, H6) , and 4.11 (J 12 and 2 Hz, H6). 
To establish the connectivity (location) of the C16 
and C49 ortho ester linkages, a well established egra- 
dation sequence previously applied to EV-B and EV-D 
[2, 4] was followed. Permethylation of Me-EV-6 2 with 
Mel /NaH in tetrahydrofuran provided 3. Two-phase 
aqueous hydrolysis of 3 gave 5 and 7, which were 
separated by chromatography on silica gel column. 
Treatment of the ester 5 with methanolic diazomethane 
yielded 9 and 12, which were identical by NMR, mass 
spectrometry, and TLC to the corresponding products 
obtained from permethylated EV-2 [5]. The degradation 
product 12 was also identical by NMR, mass spectrom- 
etry, and TLC to the product obtained by the same 
method with EV-D [4]. Treatment of the more polar 
ester 7 with methanolic diazomethane, as; above, gave 
14, which was identical (NMR, mass spectrometry, 
TLC) to the product isolated from EV-D. Thus, the site 
of the attachment of the two orthoester linkages in EV-6 
is established to be the same as in EV-2 and EV-D. The 
FAB mass spectral data that further confirmed our 
structural assignments are discussed below. 
Mass Spectrometry 
FAB mass spectra were obtained on the JEOL JMS- 
HX110A mass spectrometer quipped with a FAB gun 
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using xenone gas: the source was operated at an accel- 
erating voltage of 10 kV and the FAB gun at an 
accelerating voltage of 3 kV and emission current of 10 
mA. Liquid secondary ion mass spectrometry (LSIMS) 
work was obtained on a VG-ZAB-SE mass spectrometer 
operated at 8 kV equipped with a cesium ion gun 
operated at 25 kV. A few crystals of EV-6 was dissolved 
in 1-2 ~L of DMSO and a few crystals of NaC1 were 
usually added to this solution. The DMSO solutions 
were mixed with 1 ~L of various matrices: glycerol, 
thioglycerol, glycerol/thioglycerol, 3-nitro-benzyl a co- 
hol (3NBA), and 3NBA + NaC1, with the last matrix 
producing the best results. A thin layer of the above 
solution was then applied to the FAB probe and intro- 
duced into the instrument. For the peak matching 
experiment, a cyclic peptide, with a molecular formula 
of C63H96N12021, was  added to the EV-6 solution as the 
reference compound. This peak matching experiment 
was performed at a mass resolving power of 5000. 
Electrospray studies were performed on a Sciex API III 
triple quadrupole mass spectrometer. About 20 ~L 
methanol solution (1 ~g/~L) of EV-6 was introduced by 
direct infusion or via a short C1~ column [4.6 mm inner 
diameter (i.d.) × 1 cm] using 95% acetonitrile/5% H20 
with 0.03% trifluoroacetic acid. An orifice voltage of 40 
V was applied for the direct infusion ESI analysis. For 
tandem mass spectrometry experiments, an orifice volt- 
age of 70 V and a collision energy of 76 eV with collision 
gas (Ar) thickness of 290 were used. The sample was 
introduced at a flow rate of 5 ~L/min into the mass 
spectrometer with a nebulizing as flow at 0.6 L/min. 
Results and Discussion 
Everninomicins are essentially nonvolatile oligosaccha- 
ride compounds that do not yield molecular ion infor- 
mation by electron ionization (EI), chemical ionization 
(CI), and direct chemical ionization (DCI) mass spec- 
trometry. Plasma desorption, laser desorption, and elec- 
trospray yielded molecular ions but with little struc- 
turally informative fragmentation. FAB-MS yields 
abundant ions plus detailed fragmentation data delin- 
eating the structure of all everninomicin components. 
Positive ion electrospray ionization (ESI) of everni- 
nomicin yielded strong molecular ion data but pro- 
duced only limited structurally useful fragmentation. 
The ESI-MS spectrum displayed abundant ions at m/z 
827, 701, and 365 that involved cleavage of the sugar 
ether linkages, thus providing partial insight into the 
sugar sequence of the right portion of EV-6 as taken 
from the central ortho ester group. These ions corre- 
spond to the FAB-produced sodiated ions of m/z 849, 
723, and 387 observed in the FAB spectrum (see Figure 
3). Discussion of the FAB data is provided later. How- 
ever, the ESI spectrum did not provide clear structural 
information defining the left portion of the molecule. It 
was also found that ESI was hindered by a problem that 
both ortho ester groups in everninomicin undergo hy- 
drolysis during sample introduction, thus producing a
complex spectrum. 
ESI tandem mass spectrometry studies provided 
information partially defining the portion to the right of 
the central ortho ester of EV-6 but failed to provide an 
ion series for the left portion of the molecule. However, 
this technique did produce an abundant ion of m/z 233 
that involved the aromatic moiety; this ion was ob- 
served to increase by the expected 14 mass units to m/z 
247 for the mono-methyl ether of EV-6 (compound 2). 
Irregardless of which ion was used in the tandem mass 
spectrometry experiment for EV-6 [M + H] + or [M + 
Na] ÷, the same ions (m/z 849, 723, 485, and 359) were 
observed in the spectrum. These ions all ,contain Na + 
and involve the right portion of the EV-6 molecule. The 
ions of m/z  849 and 723 are observed in both FAB (see 
Figure 3) and regular ESI, but the m/z 485 and 359 ions 
were not observed by either of these techniques, and 
involved small fragments of the molecule generated 
from the middle of the sugar backbone (the m/z 485 
involved rings E-G and the m/z 359 involved rings F 
and G). 
In summary, we obtained partial structural informa- 
tion corresponding tothe right portion of EV-6 but were 
unable to define the left portion of the molecule using 
ESI-MS. In addition, fragmentation was more complex 
because some EV-6 hydrolyzed uring the experiment. 
It will be shown below that the positive ion FAB-MS 
provides more complete information that is useful for 
the structural characterization f this new oligosaccha- 
ride antibiotic, EV-6. 
FAB spectra of EV-6 were initially obtained by using 
a 50:50 glycerol/thioglycerol (g y/thio) matrix and pro- 
duced a very weak protonated molecular [M + H] + ion 
at m/z 1335 and a very low-abundance sodiated mo- 
lecular ion at m/z 1357 (Figure 1): it should be noted 
that everninomicins did not yield molecular ions when 
desorbed from a straight glycerol matrix, although 
fragment ions of interest were observed. The cationized 
low-abundance m/z 1357 ion was due to the presence 
of trace amounts of Na salt in the sample. Although the 
results of these initial FAB studies were comparatively 
limited in value, some structural insight could be ob- 
tained. The mass spectrum showed fragment ions at 
m/z 233, 345, and 363 that partially define the portion 
of the EV-6 molecule to the left of the central ortho ester 
and an ion at m/z 827 formed by the right portion of the 
molecule. 
Much better results have since been obtained with 
3NBA and NaCI doped 3NBA as the matrices. In earlier 
structural studies with thermolabile organic molecules, 
natural products, and various components of everni- 
nomicin antibiotics, we and other groups [4, 6, 7, 13-17] 
demonstrated the importance of salt addition in 
FAB-MS for enhancement of their spectra. This tech- 
nique of using NaC1 in LSIMS and FAB yielded strongly 
enhanced sodiated molecular ions plus detailed sugar 
sequencing information. The addition of NaC1 to the 
gly/thio matrix produced abundant sodiated molecular 
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Figure 1. FAB-MS of EV-6 with 50:50 thioglycerol-glycero! as the matrix; trace amounts  of Na salt 
present as a contaminant.  
ions and structurally informative fragment :ions. Addi- 
tional fragment ions were observed in this spectrum, 
arising from the substantial displacement of the aro- 
matic chlorines. The displacement of the aromatic hlo- 
rines were also observed when glycerol, thioglycerol, 
and gly/thio were used as the matrix without the 
addition of NaC1. These ion series, involving successive 
displacements of the aromatic hlorines with hydrogen, 
were reported earlier in several mass spectrometry 
papers [6, 7, 14] on everninomicin, but were not ob- 
served here with 3NBA as the matrix. 
The use of DMSO as the solvent and 3NBA as the 
matrix with NaC1 addition produced the best results. 
We now make a careful evaluation of the FAB spectrum 
of EV-6 (see Figures 2 and 3) and then compare these 
results with those obtained for EV-D (Figure 4). EV-D is 
the main component in the fermentation broth produc- 
ing this group of oligosaccharides, and its structure has 
been extensively studied by us, thus making it a good 
model for comparison. We reached the following con- 
clusions; (a) EV-6 has no nitro-sugar, (b) rings b, c, d, e, 
f, h, j, and k of EV-6 (Figure 3) have identical composi- 
tions and the same sequence as EV-D, and (c) sugar g 
has a -CH2OH group in place of the --CH2OCH 3 group 
of EV-D. 
Figure 2 shows the FAB spectra of EV-6 with a 
3NBA + NaC1 matrix. This matrix resulted in an 
abundant sodiated molecular ion [M + Na] + at m/z 
1357. Considerable nhancement of the molecular ion 
with the addition of salt [14] to the FAB matrix was 
observed for all everninomicins. An insert in Figure 2 
provides a blowup of the molecular ion region to 
illustrate the dichloride isotope pattern of EV-6, ions of 
m/z 1357, 1359, and 1361. The peak, 18 u higher, that is 
observed at m/z 1375, is due to the partial hydrolysis of 
the ortho ester between sugar c and e during the long 
storage of the sample. An accurate mass of 1357.4283 
was obtained for the sodiated molecular ion by peak 
matching, and this result was in good agreement with 
an elemental composition of C57H84OBICl::Na (calculat- 
ed, 1357.4271). 
The NaCl-doped positive ion FAB of EV-6 produced 
several series of structurally informative ions consistent 
with cleavage at successive sugar units in this molecule; 
Figure 3 illustrates the fragment ions observed in the 
above spectrum (Figure 2). An important series of ions 
(of m/z 1023, 893, 751, 591, and 415) involving the 
portion of the molecule to the right of the central 
ortho-ester is consistent with successive cleavage at the 
anomeric carbons of the various sugars [17(a)]. Two 
other sets of ions (m/z 995, 849, 723, 563, 387, 219 and 
1107, 977, 833, 705 and 545) also map the right portion 
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Figure 2. NaC1 enhanced positive ion FAB-MS of EV-6 using 3NBA as the matrix: insert illustrates 
expanded molecular ion region. 
of EV-6 and involve cleavages at the ether linkages. The 
low-abundance ion at m/z  219 is formed by cleavage of 
the ortho-ester joining ring h and j and is also observed 
with EV-D. The presence of the di-C1 aromatic moiety, 
marked by the two-chlorine isotope pattern, defines the 
left portion of EV-6. A series of fragment ions is 
observed containing a two-chlorine isotope pattern, 
starting with the sodiated lactone fragment at m/z  531 
and includes the m/z  363, 345, and 233 fragment ions. 
Figure 4 presents the mass spectral data of EV-D 
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Figure 3. Structure of EV-6 demonstrating structurally informative ions found in spectrum shown in 
Figure 2. 
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Figure 4. Structure of EV-D with structurally informative ions obtained by NaCI enhanced positive 
ion FAB-MS, presented for comparison to EV-6. 
obtained on the JEOL JMS-HX110A mass spectrometer 
with NaCl-doped 3NBA as the matrix. The table below 
compares the above three fragmentation series involv- 
ing the right portion of EV-6 with the corresponding 
series for EV-D; it is important o note that ions of m/z 
415, 387, and 219 are observed for both compounds, 
indicating no structural differences for this portion of 
the molecule. 
EV-6 1023, 893, 751,591,415 
EV-D 1037, 907, 765, 605, 415 
EV-6 995, 849, 723, 563, 387, 219 
EV-D 1009, 863, 737, 577, 387, 219 
EV-6 977, 833, 705, 545 
EV-D 991,847, 719, 559 
A difference of 14 u is observed in fragments containing 
ring g; this 14-u mass difference is maintained through- 
out the remainder of the fragment series. This mass 
difference is consistent with the replacement of the 
-CHaOCH 3 group in the g ring of EV-D with a -CH2OH 
group in EV-6. Thus, EV-6 has the same sugar sequence 
as EV-D, allowing for the 14 u difference resulting from 
the different g ring substituent. In addition, because 
rings b -k  are identical for both everninomicins, except 
for the 14 u difference in ring g, and because the 
aromatic ester group is also shown to be identical (ions 
of m/z 233, 345, and 363), it follows that the remaining 
difference in mass is due to the absence of the nitro 
sugar; the accurate mass measurements are consistent 
with this assignment. 
The standard chemical and mass-spectral procedure 
for confirming the presence of the phenol ester attached 
to sugar b of all everninomicins involved methylation of 
this phenol group. Compound 2, formed by methyl- 
ation of EV-6 1 with diazomethane, produced a species 
that gave an [M + Na] + at m/z 1371. The NaCl-doped 
matrix gave a FAB-MS spectrum (Figure 5) of this 
compound that contained the same cleavage sequences 
as EV-6, with the exception that the ions of m/z 531, 
363, 345, and 233 have been shifted 14 u higher to m/z 
545, 377, 359, and 247, respectively, thus being consis- 
tent with methylation of the aromatic hydroxy group. 
We have also investigated the use of negative ion 
FAB-MS for the structural analysis of everninomicins, 
and this technique appears to be an extremely powerful 
tool for the characterization of these oligosaccharide 
antibiotics [18]. The results of our negative-ion FAB 
study, covering all known everninomicins, will be re- 
ported as a separate article. A brief discription of the 
results for EV-6 are mentioned here. 
Negative-ion FAB-MS analysis of EV-6 was per- 
formed in the DMSO-3NBA matrix without the addi- 
tion of NaC1. It produced an abundant molecular ion 
[M - HI - ,  at m/z 1333 and a series of ions of m/z 987, 
811, 651, 507, and 377, resulting from the successive 
cleavage, from right to left (h-c), of the ether linkages 
between the sugar groups. In addition to this series, 
there was an ion at m/z 1133 due to the loss of sugar j
and ring k with a transfer of two hydrogens to the 
observed ion. The presence of ion at m/z 249 corre- 
sponded to the aromatic ester function containing two 
chlorine ions. In general, negative-ion FAB-MS pro- 
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Figure 5. NaC1 enhanced spectrum of methyl-EV-6 in 3NBA. 
duces an abundant  molecular  ion and a f ragment ion 
series that clearly defines the sugar sequence. 
Conc lus ions  
We have found that the novel everninomicin compo- 
nent, EV-6 1, closely resembles the structure to EV-D; 
(a) EV-6 has no nitro sugar, which is unique within the 
everninomicin family, (b) sugars b, c, d, e, f, h, j, and k 
have identical composit ions and sequences as those in 
EV-D, and (c) sugar g is the same except hat a -CH2OH 
group has replaced the --CH2OCH 3 group of EV-D. This 
article again i l lustrates the importance of posit ive ion 
FAB (LSIMS) in the mass spectrometry analysis of 
complex ol igosaccharides of the type represented by the 
everninomicin family, as well  as the fol lowing points: 
(a) that the use of 3NBA and NaC1 for FAB analysis of 
everninomicins produced abundant  sodiated molecular  
ions plus fragmentat ion series that define the sequence 
of the sugar chain; and (b) that 3NBA d id  not produce 
displacement of the aromatic chlorines as observed 
when glycerol / th ioglycerol  was the matr ix and that 
although ESI p roduced valuable information for EV-6, 
the results obtained with FAB were superior.  
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